Skip to content
Angiotensin Therapeutics Logo Angiotensin Therapeutics Logo Angiotensin Therapeutics Logo
  • Overview
  • Who We Are
  • Leadership Team
  • Advisors
  • News
Home/About/News
NewsNick Batlle2023-05-10T16:52:51+00:00

News

Bioengineered Protein May Prevent COVID Infections and Improve Survival  Northwestern Medicine


Study Shows Cell Membrane-Bound Enzyme is Essential for COVID-19 Infection  Northwestern Medicine


Angiotensin Therapeutics Inc. announces publication of a study using a soluble ACE2 protein designed for COVID-19  Press Release


A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection  Journal of the American Society of Nephrology


Can you spot the fake receptor? The coronavirus can’t either.  MIT Technology Review


Podcast: Kidneys, COVID-19 and ACE2 Connection with Daniel Batlle, MD  Northwestern University


Fooling coronavirus with new decoy protein renders it impotent   Northwestern University


Novel protein construct prevents lethal COVID-19 in mice   News Medical


Angiotensin Therapeutics Inc. Announces Publication of a Novel Approach to COVID 19 Therapy. Press Release.   


Angiotensin Therapeutics Inc. Announces Publication of a Novel Approach to COVID 19 Therapy.  BioSpace.   


New Protein Neutralizes COVID in Tiny Human Kidney.  Northwestern University.   


  • © 2020 Angiotensin Therapeutics Inc.
  • Contact
  • About
  • News
Go to Top